Marcella, Simone (2022) Vascular Endothelial Growth Factors and Angiopoietins as New Players in Mastocytosis. [Tesi di dottorato]

[thumbnail of Marcella_Simone_34.pdf]
Anteprima
Testo
Marcella_Simone_34.pdf

Download (1MB) | Anteprima
Tipologia del documento: Tesi di dottorato
Lingua: English
Titolo: Vascular Endothelial Growth Factors and Angiopoietins as New Players in Mastocytosis
Autori:
Autore
Email
Marcella, Simone
s.marcella92@gmail.com
Data: 2 Marzo 2022
Numero di pagine: 46
Istituzione: Università degli Studi di Napoli Federico II
Dipartimento: Scienze Mediche Traslazionali
Dottorato: Medicina clinica e sperimentale
Ciclo di dottorato: 34
Coordinatore del Corso di dottorato:
nome
email
Beguinot, Francesco
beguino@unina.it
Tutor:
nome
email
Loffredo, Stefania
[non definito]
Data: 2 Marzo 2022
Numero di pagine: 46
Parole chiave: angiopoietins; ANGPT; mast cells; mastocytosis; stem cell factor; tryptase; vascular endothelial growth factors; VEGF-A; VEGF-C
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/05 - Patologia clinica
Area 06 - Scienze mediche > MED/09 - Medicina interna
Depositato il: 17 Mar 2022 08:41
Ultima modifica: 28 Feb 2024 14:16
URI: http://www.fedoa.unina.it/id/eprint/14588

Abstract

Background: Mastocytosis is a disorder characterized by the abnormal proliferation and/or accumulation of mast cells in different organs. More than 90% of patients with systemic mastocytosis have a gain-of-function mutation in codon 816 of the KIT receptor on mast cells (MCs). The symptoms of mastocytosis patients are related to the MC-derived mediators that exert local and distant effects. MCs produce angiogenic and lymphangiogenic factors, including vascular endothelial growth factors (VEGFs) and angiopoietins (ANGPTs). Methods: Serum concentrations of VEGF-A, VEGF-C, VEGF-D, ANGPT1 and ANGPT2 were determined in 64 mastocytosis patients and 64 healthy controls. Intracellular concentrations and spontaneous release of these mediators were evaluated in the mast cell lines ROSAKIT WT and ROSAKIT D816V . Results: VEGF-A, ANGPT1, ANGPT2 and VEGF-C concentrations were higher in mastocytosis patients compared to controls. The VEGF-A, ANGPT2 and VEGF-C concentrations were correlated with the symptom severity. ANGPT1 concentrations were increased in all patients compared to controls. ANGPT2 levels were correlated with severity of clinical variants and with tryptase levels. VEGF-A, ANGPT1 and VEGF-C did not differ between indolent and advanced mastocytosis. ROSAKIT WT and ROSAKIT D816V contained and spontaneously released VEGFs and ANGPTs. Conclusion: Serum concentrations of VEGFs and ANGPTs are altered in mastocytosis patients.

Downloads

Downloads per month over past year

Actions (login required)

Modifica documento Modifica documento